Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Has announcements × Cetuximab × Head & Neck × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 5 Head & Neck 1

Conditions

Parkinson Disease 4, Autosomal Dominant Lewy Body 1 Head and Neck Neoplasms 1

Interventions

pembrolizumab 3 Cisplatin 3 selpercatinib 2 entrectinib 2 Carboplatin 2 trametinib 1 toripalimab 1 repotrectinib 1 pralsetinib 1 penpulimab 1 larotrectinib 1 dabrafenib 1 cabozantinib 1 Gemcitabine 1 Fluorouracil 1 Cetuximab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02358031 2025-07-18

MK-3475-048

Merck Sharp & Dohme LLC

Phase 3 Completed

882 enrolled 50 charts 1 FDA

Parkinson Disease 4, Autosomal Dominant Lewy Body, Head and Neck Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡